Most cases of Rett syndrome are caused by a change (also called a mutation) in a single gene. In 1999, NICHD-supported scientists discovered that most classic Rett syndrome cases are caused by a mutation within the Methylcytosine-binding protein 2 (MECP2) gene. The MECP2 gene is located on the X chromosome. Between 90% and 95% of girls with Rett syndrome have a mutation in the MECP2 gene.1,2,3 Among families with a child affected by Rett syndrome the chance of having a second child with the syndrome is very low.4
Eight mutations in the MECP2 gene represent the most prevalent causes of Rett syndrome. The development and severity of Rett syndrome symptoms depend on the location and type of the mutation on the MECP2 gene.5
The MECP2 gene makes a protein that is necessary for the development of the nervous system, especially the brain. The mutation causes the gene to either make insufficient amounts of this protein or to make a damaged protein that the body cannot use. In either case, if there is not enough of the working protein for the brain to develop normally, Rett syndrome develops.
Researchers are still trying to understand exactly how the brain uses this protein, called MeCP2, and how problems with this protein cause the typical features of Rett syndrome.
Mutations on two other genes can cause some of the atypical variants of Rett syndrome: Congenital Rett syndrome (Rolando variant) is associated with mutations of the FOXG1 gene, and CDKL5 mutations are linked with the early-onset, or Hanefeld, variant.6,7 Males affected by these types of mutations can survive infancy. Males can also have a duplication of a normal MECP2 gene and survive, but are severely affected. Too much MeCP2 protein is as bad for development as too little.
Is Rett syndrome passed from one generation to the next?
In nearly all cases, the genetic change that causes Rett syndrome is spontaneous, meaning it happens randomly. Such random mutations are usually not inherited or passed from one generation to the next. However, in a very small percentage of families, Rett mutations are inherited and passed on by female carriers.2,8
Why do mostly females and so few boys have Rett syndrome?
Two types of chromosomes determine the sex of an embryo: the X and the Y chromosomes. Girls have two X chromosomes, and boys have one X and one Y chromosome.
Because the mutated gene that causes Rett syndrome is located on the X chromosome, females have twice the opportunity to develop a mutation in one of their X chromosomes. Females with Rett syndrome usually have one mutated X chromosome and one normal X chromosome. Only one X chromosome in a given cell remains active throughout life and cells randomly determine which X chromosome will remain active. If the cells have an active mutated gene more often than the normal gene, the symptoms of Rett syndrome will be more severe. This random process allows most females with Rett syndrome to survive infancy.
Because most boys have only one X chromosome, when this gene is mutated to cause Rett syndrome the detrimental effects are not softened by the presence of a second, normal X chromosome. As a result, many males with Rett syndrome are stillborn or do not live past infancy.6,9
Some boys with Rett syndrome, however, do live past infancy, likely for one of three reasons:
- Mosaicism (pronounced moh-ZEY-uh-siz-uhm), a condition in which individual cells within the same person have a different genetic makeup. This means that some of the X chromosome genes in a boy's body have the Rett mutation, and some genes do not have the mutation. When a lower percentage of genes have the Rett syndrome mutation, the symptoms are not as severe.
- A boy may have two X chromosomes and one Y chromosome (Klinefelter syndrome). Only one X chromosome will be active in each cell, so if one X carries a mutation in MECP2, the severity of symptoms will depend on how many cells have that the mutant X active in the body.
- The genetic mutation is less severe than that of other forms of Rett syndrome mutations.9
Duplication of the MECP2 gene can occur in boys and affects intellectual and physical function.
- Amir, R. E., Van den Veyver, I. B., Wan, M., Tran, C. Q., Francke, U., & Zoghbi, H. Y. (1999). Rett syndrome is caused by mutations in X-linked MECP2. Nature Genetics, Oct;23(2), 185–188.
- Schollen, E., Smeets, E., Deflem, E., Fryns, J. P., & Mathis, G. (2003). Gross rearrangements in the MECP2 gene in three patients with Rett syndrome: Implications for routine diagnosis of Rett syndrome. Human Mutations, 22, 116–120.
- Zoghbi, H.Y. (2005). MeCP2 dysfunction in humans and mice. Journal of Child Neurology, 20, 736–740.
- Rett Syndrome Research Trust. (2011). Rett syndrome. Retrieved June 21, 2012, from https://www.ninds.nih.gov/Disorders/Patient-Caregiver-Education/Fact-Sheets/Rett-Syndrome-Fact-Sheet
- Percy, A. K., Lane, J. B., Childers, J., Skinner, S., Annese, F., Barrish, J., et al. (2007). Rett syndrome: North American database. Journal of Child Neurology, Dec;22(12), 1338–1341. Retrieved June 23, 2012, from http://www.ncbi.nlm.nih.gov/pubmed/18174548
- Mari, F., Azimonti, S., Bertani, I., Bolognese, F., Colombo, E., Caselli, R., et al. (2005). CDKL5 belongs to the same molecular pathway of MeCP2 and it is responsible for the early-onset seizure variant of Rett syndrome. Human Molecular Genetics, Jul 15;14(14), 1935–1946. Retrieved June 23, 2012, from http://www.ncbi.nlm.nih.gov/pubmed/15917271
- Jacob, F. D., Ramaswamy, V., Andersen, J., & Bolduc, F. V. (2009). Atypical Rett syndrome with selective FOXG1 deletion detected by comparative genomic hybridization: Case report and review of literature. European Journal of Human Genetics, 17, 1577–1581. Retrieved June 23, 2012, from http://www.nature.com/ejhg/journal/v17/n12/full/ejhg200995a.html
- Percy, A. K., Dragich, J., & Schanen, C. (2003). Rett Syndrome: Clinical-Molecular Correlates. In G. Fisch (Ed.), Genetics and neurobehavioral disorders (pp. 391–418). Totowa, NJ: Humana Press.
- Weaving, L. S., Ellaway, C. J, Gécz, J., & Christodoulou, J. (2005). Rett syndrome: Clinical review and genetic update. Journal of Medical Genetics, 42, 1–7.